Induction-maintenance (5 → 3 drugs) in HIV-infected patients with high viral load

AIDS Patient Care and STDs

Volumn 14, Issue 11, 2000, Pages 573-574

  Soriano, Vincent ^a   Barreiro, Pablo ^a   Gonzalez Lahoz, Juan ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; NELFINAVIR; NEVIRAPINE; SAQUINAVIR; STAVUDINE;

CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LETTER; PATIENT COMPLIANCE; VIRUS INDUCTION; VIRUS LOAD;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HUMANS; LAMIVUDINE; NELFINAVIR; NITRILES; PROSPECTIVE STUDIES; PYRROLIDINES; REMISSION INDUCTION; SAQUINAVIR; STAVUDINE; TREATMENT OUTCOME; VIRAL LOAD;

EID: 0033768511     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/10872910050193734     Document Type: Letter

References (6)

1. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 infected patients: A prospective cohort study
2. Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy
3. TRILEGE: A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients
4. Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV-RNA after triple drug therapy
5. Maintenance therapy after quadruple induction therapy in HIV-1-infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study
6. Virological failure and adherence to antiretroviral therapy in HIV-infected patients